@article{41f00d0df04c4d539c507d2115a87762,
title = "Exacerbation of Racial Disparities in Living Donor Kidney Transplantation during the COVID-19 Pandemic",
abstract = "Key Points: The coronavirus disease 2019 (COVID-19) pandemic profoundly impacted transplant services, with a particularly strong impact on living donor kidney transplantation. The COVID-19 pandemic appears to have disproportionately impacted Black patients' access to living donor kidney transplantation. As the pandemic evolves through surges and vaccine acceptance disparities persist, ongoing attention to transplant disparities is needed.",
keywords = "COVID-19, SARS-CoV-2, access, disparities, kidney transplantation, living donor transplantation, transplantation",
author = "Neeraj Singh and Ruixin Li and Tarek Alhamad and Schnitzler, {Mark A.} and Mannon, {Roslyn B.} and Doshi, {Mona D.} and Woodside, {Kenneth J.} and Hippen, {Benjamin E.} and Matthew Cooper and Jon Snyder and Axelrod, {David A.} and Lentine, {Krista L.}",
note = "Funding Information: K.L. Lentine receives research funding related to living donation from the National Institutes of Health (R01DK120551) and is also supported by the Mid-America Transplant/Jane A. Beckman Endowed Chair in Transplantation. Acknowledgments Funding Information: T. Alhamad reports consultancy for CareDx, Mallinckrodt, and Veloxis; research funding from Angion, CareDx, Europhines, and Natera; honoraria from CareDx, Sanofi, and Veloxis; an advisory or leadership role for CareDx, Europhines, and QSANT; and participation in a speakers{\textquoteright} bureau for CareDx, Sanofi, and Veloxis. D.A. Axelrod reports consultancy for CareDx and Talaris; ownership interest in CareDx; and service on the NKF policy committee. M. Cooper reports consultancy for CareDx, Natera, and Specialist Direct; honoraria from CareDx; and an advisory or leadership role for the American Foundation for Donation and Transplant, Angion Pharmaceuticals, Donate Life America, International Pancreas and Islet Cell Transplant Association, National Kidney Foundation, National Kidney Registry, Quark Pharmaceuticals, Transplant Genomics, and UNOS. B.E. Hippen reports being employed by Fresenius Medical Care; ownership interest in Interwell Health; prior service on the board of directors for InterWell Health, and currently an (uncompensated) scientific advisory board member of eGenesis Bio. K.L. Lentine reports consultancy for CareDx; participation in a speakers{\textquoteright} bureau for Sanofi; service on the ASN Policy and Advocacy Committee, and the NKF Transplant Advisory Committee; and is chair of the AST Living Donor Community of Practice, and a senior scientist of the SRTR. R.B. Mannon reports consultancy for Scientific Advisory Committee and Verici DX; research funding from Astellas, CareDx, CSL Behring, Mallinckrodt, Quark Pharmaceuticals, Transplant Genomics, and Verici DX; honoraria from CSL Behring, Hansa, Novartis, Sanofi, and Vitaerris; patents or royalties from Eurofins; an advisory or leadership role with the Steering Committee of Vitaerris VKTX01 IMAGINE Trial; and is chair of the DSMB, NIDDK/NIH, ASN Policy and Advocacy Committee, Women in Transplantation, on the Program Committee for TTS 2020 and 2022, and is co-chair of the SRTR Review Committee. M. Schnitzler reports consultancy for CareDx and honoraria from OPTUM. N. Singh reports consultancy for CareDx, Mallinckrodt, Natera, Transplant Genomics, and Veloxis Pharmaceutics; research funding from CareDx and Transplant Genomics; honoraria from CareDx, Mallinckrodt, Natera, Transplant Genomics, and Veloxis; is co-chair of AST KPCOP; and participated in a speakers{\textquoteright} bureau for CareDx, Mallinckrodt, Natera, Transplant Genomics, and Veloxis Pharmaceutics. J. Snyder reports research funding from Astellas, Atara Biotherapeutics, CSL Behring, Novartis, and Vertex; is a board member of the Organ Donation and Transplantation Alliance and Donate Life America, and on the Clinical Policy Board LifeSource; is associate editor of Transplantation and statistical editor of American Journal of Transplantation; and is director of the Registry of Transplant Recipients (RTR). K.J. Woodside reports consultancy for Laminate; ownership interest in Nephrodite; research funding from Laminate; and an advisory or leadership role for the Gift of Life Michigan-Organ Committee. All remaining authors have nothing to disclose. Publisher Copyright: Copyright {\textcopyright} 2022 by the American Society of Nephrology.",
year = "2022",
month = jun,
day = "30",
doi = "10.34067/KID.0008392021",
language = "English (US)",
volume = "3",
pages = "1089--1094",
journal = "Kidney360",
issn = "2641-7650",
publisher = "Lippincott Williams and Wilkins",
number = "6",
}